Clinical Trial Update: Long-term Impact of NMDAR Encephalitis

View source ↗

Summary

A completed clinical trial update examining the long-term outcomes of autoimmune encephalitis associated with NMDA receptor antibodies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anti-nmda Receptor Encephalitis
• Autoimmune Encephalitis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Autoimmune Encephalitis | Status: COMPLETED